Protein Polybromo-1

Protein polybromo-1 (PBRM1, also known as BAF180) is a defining subunit of the PBAF chromatin-remodeling complex and functions in transcriptional activation and repression through regulation of chromatin structure and DNA-nucleosome topology^[1][2][6]. PBRM1 contains six bromodomains that recognize acetylated lysine residues on histones and other nuclear proteins, thereby linking epigenetic histone modifications to chromatin accessibility and transcriptional control^[2][3][4]. Mechanistically, bromodomain-mediated recognition of acetylated histones contributes to selective targeting of chromatin regions, and bromodomain 2 preferentially recognizes histone H3 lysine 14 acetylation (H3K14ac), a mark associated with transcriptional activation^[4]. In disease contexts, PBRM1 is widely regarded as a tumor suppressor, and recurrent mutations are particularly prevalent in clear cell renal cell carcinoma, where disruption of PBRM1-associated chromatin regulation is linked to altered transcriptional programs^[5]. Experimental studies further indicate that PBRM1-deficient PBAF complexes can activate the NF-κB pathway through aberrant genomic targeting in renal cancer models^[5]. Compared with related SWI/SNF-family subunits, PBRM1 is distinguished by its unique architecture comprising six bromodomains together with two BAH domains and an HMG-associated region, supporting specialized chromatin-recognition functions within the PBAF complex^[3]. The bromodomains of PBRM1 are therefore important research targets for investigating epigenetic regulation, chromatin remodeling mechanisms, and the functional consequences of cancer-associated variants^[2].